PYCTX Ltd (PYC):企業の財務・戦略的SWOT分析

◆英語タイトル:PYCTX Ltd (PYC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82400FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PYCTX Ltd (PYCTX), formerly Phylogica Ltd is a biotechnology company that develops intracellular biological therapeutics. The company utilizes proprietary phylomer peptide libraries and screening methodologies to identify unique peptide drug candidates. Its products include libraries and peptides. Phylogica’s Phylomer libraries are in variety of phage display and yeast-two-hybrid formats and in mammalian expression vectors for phenotypic screening through which peptides are derived. The company’s oncology candidate’s pipeline programs include Myc, STAT5 and YB1. The company discovers and patents peptide therapeutics which exhibit competitive therapeutic, manufacturing, and commercial advantages over proteins, monoclonal antibodies and most current therapeutic peptides. PYCTX is headquartered in Mount Pleasant, Australia.

PYCTX Ltd Key Recent Developments

Mar 29,2021: PYC Therapeutics Appoints U.S. Biopharma Executive Jason Haddock to its Board of Directors
Mar 26,2021: PYC Therapeutics announces retirement of Dr. Bernard Hockings as board director
Mar 17,2021: PYC Therapeutics appoints US Biotech Veteran Michael Rosenblatt to its Board of Directors
Feb 23,2021: PYC Therapeutics Expands U.S. Executive Leadership Team with the Appointment of Glenn Noronha, PhD, as Chief Development Officer
Feb 22,2021: PYC Therapeutics highlights progress in its transformation to a U.S. clinical-stage company and 2021 corporate objectives

This comprehensive SWOT profile of PYCTX Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of PYCTX Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

PYCTX Ltd – Key Information
PYCTX Ltd – Overview
PYCTX Ltd – Key Employees
PYCTX Ltd – Key Employee Biographies
PYCTX Ltd – Key Operational Heads
PYCTX Ltd – Major Products and Services
PYCTX Ltd – History
PYCTX Ltd – Company Statement
PYCTX Ltd – Locations And Subsidiaries
PYCTX Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

PYCTX Ltd – Business Description
PYCTX Ltd – Corporate Strategy
PYCTX Ltd – SWOT Analysis
SWOT Analysis – Overview
PYCTX Ltd – Strengths
PYCTX Ltd – Weaknesses
PYCTX Ltd – Opportunities
PYCTX Ltd – Threats
PYCTX Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

PYCTX Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

PYCTX Ltd, Key Information
PYCTX Ltd, Key Ratios
PYCTX Ltd, Share Data
PYCTX Ltd, Major Products and Services
PYCTX Ltd, History
PYCTX Ltd, Key Employees
PYCTX Ltd, Key Employee Biographies
PYCTX Ltd, Key Operational Heads
PYCTX Ltd, Other Locations
PYCTX Ltd, Subsidiaries
PYCTX Ltd, Key Competitors
PYCTX Ltd, SWOT Analysis
PYCTX Ltd, Ratios based on current share price
PYCTX Ltd, Annual Ratios
PYCTX Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[PYCTX Ltd (PYC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Steven Madden Ltd (SHOO):企業の財務・戦略的SWOT分析
    Steven Madden Ltd (SHOO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Digirad Corp (DRAD)-医療機器分野:企業M&A・提携分析
    Summary Digirad Corp (Digirad) is a medical device company that offers mobile and on-site imaging solutions. The company offers camera products which include ergo, cardius x-ACT, cardius 2 XPO, corcam, quantumcam, and cardius 3 XPO. Its diagnostic services include nuclear cardiology, ultrasound, neu …
  • Rotala Plc:企業の戦略・SWOT・財務情報
    Rotala Plc - Strategy, SWOT and Corporate Finance Report Summary Rotala Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Fox Chase Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Fox Chase Cancer Center (Fox Chase), formerly American Oncologic Hospital Inc, a subsidiary of Temple University Health System Inc, is a healthcare service provider that offers cancer care services. The center provides screening services for breast, colorectal, prostate, lung and skin cancer …
  • eFFECTOR Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary eFFECTOR Therapeutics Inc (Effector) is a biopharmaceutical company that concentrates on new class of oncology drugs-selective translation regulators. The company works on the discovery and development of translation regulators as a new small molecule therapeutics that control gene expressio …
  • PSE Kinsale Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary PSE Kinsale Energy Ltd (Kinsale Energy), formerly Marathon Oil Ireland Limited, carries out the production and storage of natural gas from its facilities off the Old Head of Kinsale. The company operates Kinsale Head, Ballycotton, Seven Heads and Southwest Kinsale gas fields in the Celtic Se …
  • BPL Global LLC:企業の戦略的SWOT分析
    BPL Global LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • CBT Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CBT Pharmaceuticals Inc (CBT) is a pharmaceutical company that develops innovative medicines for cancer indications. The company's pipeline products include CBT-101, cMet inhibitor is being developed to target the epithelial to mesenchymal transition pathway. Its CBT-101 is developed for var …
  • Colonial Pipeline Company:石油・ガス:M&Aディール及び事業提携情報
    Summary Colonial Pipeline Company (Colonial) is an oil and gas company that distributes petroleum products. The company transports refined petroleum products such as gasoline, home-heating oil, kerosene, diesel fuels; and aviation fuel including jet fuel and military fuels. It provides services incl …
  • Ashtead Group Plc (AHT):企業の財務・戦略的SWOT分析
    Ashtead Group Plc (AHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Instituto Costarricense de Electricidad:企業の戦略的SWOT分析
    Instituto Costarricense de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • World Fuel Services Corporation:企業の戦略・SWOT・財務情報
    World Fuel Services Corporation - Strategy, SWOT and Corporate Finance Report Summary World Fuel Services Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Parexel International Corp:医療機器:M&Aディール及び事業提携情報
    Summary Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of …
  • Fluxys SA:企業の戦略的SWOT分析
    Fluxys SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Itochu Corporation (8001)-石油・ガス分野:企業M&A・提携分析
    Summary Itochu Corporation (Itochu) is a trading company. It offers domestic trading, import and export, and overseas trading. The company trades in products such as textile, machinery, metals, minerals, energy, chemicals, food, general products, information and communications technology, realty, in …
  • Banco Comercial Portugues SA:企業の戦略・SWOT・財務分析
    Banco Comercial Portugues SA - Strategy, SWOT and Corporate Finance Report Summary Banco Comercial Portugues SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Electricity & Water Authority:企業の戦略的SWOT分析
    Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Aoyama Trading Co., Ltd.:企業の戦略・SWOT・財務情報
    Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Mosaic Company:企業の戦略・SWOT・財務情報
    The Mosaic Company - Strategy, SWOT and Corporate Finance Report Summary The Mosaic Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Arris International Plc
    Arris International Plc - Strategy, SWOT and Corporate Finance Report Summary Arris International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆